131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma

被引：2
|
作者：
Castro, Gabriel [1 ]
Berrocal, Isabel [1 ]
Carmona, Jaime [1 ]
Gonzalez, Javiera [1 ]
Gonzalez, Patricio [1 ]
机构：
[1] Univ Chile, Clin Hosp, Nucl Med Sect, Independencia, Santiago De Chi, Chile
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷 / 08期
关键词：
Omeprazole; Differentiate Thyroid Cancer; Differentiate Thyroid Carcinoma; Radioiodine Therapy; Visual Score;
D O I：
10.1007/s00259-012-2104-1
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1356 / 1357
页数：2
相关论文
共 50 条
  • [1] 131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma
    Gabriel Castro
    Isabel Berrocal
    Jaime Carmona
    Javiera González
    Patricio González
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1356 - 1357
  • [2] Diagnostic 121I and 131I activities and radioiodine therapy -: Effects on urinary iodine excretion in patients with differentiated thyroid carcinoma
    Meller, B
    von Hof, K
    Genina, E
    Deisting, W
    Meller, J
    Richter, E
    Baehre, M
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (06): : 243 - 248
  • [3] Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 697 - 699
  • [4] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Jin, Pingyan
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Sun, Yungang
    Xian, Jialang
    Huang, Liuhua
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2018, 57 (02) : 169 - 177
  • [5] Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer
    Gortan, Fatma Arzu
    Yuksel, Alptug Ozer
    Gulaldi, Nedim Cuneyt Murat
    Coskun, Nazim
    Akca, Ceren Deniz Kapulu
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 260 - 268
  • [6] Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe, Carsten
    Eschner, Wolfgang
    Wild, Markus
    Rahlff, Ilka
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Dietlein, Markus
    Schicha, Harald
    NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (03) : 201 - 205
  • [7] Improved follow-up of patients with differentiated thyroid carcinoma The quantitative detection limit of 131I uptake in diagnostic scans
    Diessl, S.
    Verburg, F.
    Biko, J.
    Schryen, B.
    Reiners, C.
    Buck, A.
    Hanscheid, H.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2013, 52 (03): : 81 - 87
  • [8] A new method to evaluate the residual activity in patients undergoing 131I thyroid therapy
    Ostinelli, A.
    Duchini, M.
    Conti, V.
    Bonfanti, P.
    Rossi, S.
    Cacciatori, M.
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2015, 31 (08): : 1108 - 1111
  • [9] Radioiodine Therapy Induced Cytotoxicity in Patients with Differentiated Thyroid Carcinoma
    Hooman, A.
    Mogharrabi, M.
    Solooki, M.
    Mosaffa, N.
    Tabeie, F.
    Shafiee, B.
    Asli, Neshandar, I
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2008, 6 (03) : 135 - 139
  • [10] Staging of Differentiated Thyroid Carcinoma Using Diagnostic 131I SPECT/CT
    Wong, Ka Kit
    Sisson, James C.
    Koral, Kenneth F.
    Frey, Kirk A.
    Avram, Anca M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (03) : 730 - 736
12345